Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China
Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China
Recruiting · NCT07161388 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China | Limited Stage Small-Cell Lung Cancer | Recruiting | Not stated | 2026-09-11 | NCT07161388 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||